NKTX · Nkarta, Inc. · Executive Compensation
$2.35
-0.18 (-7.11%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$196.97M
Shares
71.62M
Volume · Oct 6
429.24K
Avg daily vol (3M)
638.43K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | Chief Executive Officer | $2,978,038 |
| Nadir Mahmood | President | $1,396,007 |
| Shawn Rose | M.D., Ph.D. Chief Medical Officer and Head of Research and Development | $1,224,773 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | Chief Executive Officer | $3,985,445 |
| Nadir Mahmood | President | $3,336,117 |
| David Shook | Chief Medical Officer, Head of Research and Development | $1,900,182 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | Chief Executive Officer | $2,934,715 |
| David Shook | Chief Medical Officer, Head of Research and Development | $1,510,050 |
| Alyssa Levin | Chief Financial and Business Officer | $1,286,958 |
| Nadir Mahmood | President | $820,145 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | President and Chief Executive Officer | $4,744,750 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | President and Chief Executive Officer | $6,775,031 |
| Dr. Kanya Rajangam | Chief Medical Officer | $2,590,983 |
| Dr. Nadir | Mahmood Chief Financial and Business Officer | $2,548,843 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Dr. Matthew | Plunkett | $3,871,766 |
| Dr. Alicia Hager | Chief Legal Officer and Corporate Secretary | $3,279,966 |
| Paul J. Hastings | President and Chief Executive Officer | $3,180,446 |
| Dr. Nadir | Mahmood Chief Financial and Business Officer | $2,374,379 |
| Dr. Kanya Rajangam | Chief Medical Officer | $1,418,306 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | President and Chief Executive Officer | $2,870,145 |
| Former Chief | Financial Officer | $1,056,798 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Shawn Rose, M.D. Ph.D. | Chief Medical Officer and Head of Research and Development | Appointed | 2025-06-06 |
| David Shook, M.D. | Chief Medical Officer and Head of Research & Development | Resigned | 2025-06-06 |
| Nadir Mahmood | principal accounting officer | Appointed | 2025-03-26 |
| Alyssa Levin | Chief Financial and Business Officer | Terminated | 2025-03-26 |
| Nadir Mahmood | President | Appointed | 2024-07-16 |
| Alyssa Levin | Chief Financial and Business Officer | Appointed | 2023-07-05 |
| Dr. Nadir Mahmood | Chief Financial and Business Officer | Resigned | 2023-03-30 |